Andrea Rinaldi

10PUBLICATIONS
128CO-AUTHORS
Innate immunityCancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 03, 2025
Secretory IgA amplification during immune checkpoint blockade enhances the control of tumor growth by enterotropic T cells.

Benedetta De Ponte Conti, Rebecca Marino, Tanja Rezzonico-Jost

|Sep 02, 2025
Integrated control of cancer stemness by σ1 receptor in advanced prostate cancer.

Gianluca Civenni, Giada Sandrini, Jessica Merulla

|Jul 14, 2025
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Alberto J Arribas, Francesca Guidetti, Eleonora Cannas

|Dec 05, 2023
ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms.

Alberto J Arribas, Sara Napoli, Luciano Cascione

|Nov 28, 2023
PI3Kδ activation, IL6 over-expression, and CD37 loss cause resistance to the targeting of CD37-positive lymphomas with the antibody-drug conjugate naratuximab emtansine.

Alberto J Arribas, Eugenio Gaudio, Sara Napoli

|Apr 17, 2023
IOA-244 is a Non-ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance.

Zoë Johnson, Chiara Tarantelli, Elisa Civanelli

Pageof 2

Frequent Collaborators

7 joint publications

Luciano Cascione

7 joint publications

Francesco Bertoni

6 joint publications

Chiara Tarantelli

5 joint publications

Filippo Spriano